Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBPR108 plus metformin in type 2 diabetes mellitus
CTR20192506Phase 3Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prusogliptin in type 2 diabetes mellitus (T2DM), sponsored by CSPC Pharmaceutical Group. Started Dec 2019; status: completed.
02
Drugs
prusogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192506.